Medical Care Technologies Inc. Introduces AI Facial Health Risk Estimator for Cardiovascular Disease Detection

Rhea-AI Summary

Medical Care Technologies (OTC:MDCE) has unveiled its innovative AI Facial Health Risk Estimator, a technology designed to detect early cardiovascular disease risks through advanced facial imaging analysis.

The system employs deep neural networks to analyze biometric markers including micro-wrinkle density, skin elasticity, and tone variations. By comparing biological age against chronological age, the platform can identify cardiovascular predisposition before clinical symptoms appear, offering a non-invasive alternative to traditional testing methods.

Positive

• Introduction of innovative non-invasive cardiovascular disease detection technology
• Early risk detection capability before clinical symptoms emerge
• Leverages advanced AI and deep neural networks for health assessment

Negative

• Technology is yet to be validated through clinical studies
• No information provided about regulatory approvals or FDA clearance
• Market adoption and revenue potential remains uncertain

MESA, ARIZONA / ACCESS Newswire / September 23, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced the launch of its AI Facial Health Risk Estimator, a groundbreaking technology that leverages advanced facial imaging to provide early risk detection for cardiovascular disease, one of the leading causes of death worldwide.

The system uses deep neural networks trained on biometric signatures such as micro-wrinkle density, skin elasticity, and tone variations to generate a real-time estimate of biological age. By comparing biological age against chronological age, the platform identifies cardiovascular predisposition and risk factors before clinical symptoms emerge.

"Cardiovascular disease prevention has always depended on invasive testing and delayed symptom recognition," said Marshall Perkins, CEO of MDCE. "Our AI system will deliver a non-invasive, accessible solution that empowers patients to detect early problems with their heart health."

Company Websites: www.medicalcaretechnologies.com | www.mdcestock.com

About Medical Care Technologies Inc.
Medical Care Technologies Inc. (OTC PINK: MDCE) develops AI-powered health solutions that enable early detection, preventive screening, and personalized wellness insights for systemic, ocular, and dermatological conditions.

Safe Harbor Statement:
This press release contains forward-looking statements, which are subject to risks and uncertainties that could cause actual results to differ materially.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What is Medical Care Technologies' (MDCE) new AI Facial Health Risk Estimator?

It's an AI-powered technology that analyzes facial features like micro-wrinkle density, skin elasticity, and tone variations to detect early cardiovascular disease risks by comparing biological and chronological age.

How does MDCE's AI system detect cardiovascular disease risk?

The system uses deep neural networks to analyze facial biometric signatures and calculate biological age, comparing it to chronological age to identify cardiovascular predisposition before symptoms appear.

What advantages does MDCE's AI Facial Health Risk Estimator offer over traditional methods?

It provides a non-invasive, accessible solution for cardiovascular risk detection, unlike traditional methods that rely on invasive testing and delayed symptom recognition.

Who is the CEO of Medical Care Technologies (MDCE)?

Marshall Perkins is the CEO of Medical Care Technologies Inc.